Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00939289 · ClinicalTrials.gov registry record
Concurrent Use of Two Continuous Glucose Monitoring Systems in Adults With Type 1 Diabetes Mellitus (T1DM)
A clinical trial, sponsored by DexCom.
- Completed
- Registry status
- 14
- Enrollment target
NCT00939289: Completed study, sponsored by DexCom.
NCT00939289 is a clinical trial that has completed, run by DexCom. The registered enrollment target is 14 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00939289 has completed, sponsored by DexCom.
- COMPLETED
- Registry status
- 14 participants
- Enrollment target
Study Summary
The purpose of this pilot study is to evaluate performance of the SEVEN System and the Navigator System when both devices are worn concurrently by subjects with type 1 diabetes mellitus.
Interventions
- DEVICE Continuous Glucose Monitoring
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2008-07 |
| Est. Completion | 2009-02 |
What the finished NCT00939289 record still lists
NCT00939289 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 14 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Continuous Glucose Monitoring is the first listed.
NCT00939289 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00939289 about?
NCT00939289 is a clinical study titled "Concurrent Use of Two Continuous Glucose Monitoring Systems in Adults With Type 1 Diabetes Mellitus (T1DM)". The purpose of this pilot study is to evaluate performance of the SEVEN System and the Navigator System when both devices are worn concurrently by subjects with type 1 diabetes mellitus.
What is the current status of trial NCT00939289?
This trial is currently completed. The enrollment target is 14 participants. The study started on 2008-07. Estimated completion is 2009-02.
What interventions are being tested in trial NCT00939289?
The interventions under investigation include: Continuous Glucose Monitoring (DEVICE).
Who is sponsoring clinical trial NCT00939289?
This trial is sponsored by DexCom, which has 26 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02523092 · 14 participants · Phase 4
Use of CXCL9 as a Biomarker of Acthar Efficacy
- NCT04263285 · 14 participants · NA
Treatment of Depression Post-SCI
- NCT04743271 · 14 participants · NA
Food and Circadian Timing
- NCT05065671 · 14 participants · Phase 1
Microbiome Derived Metabolism and Pharmacokinetics
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia